AIIMS Bhubaneswar Executive Director Dr. Ashutosh Biswas announced on Wednesday that Artificial Intelligence (AI) is poised to transform the early diagnosis and management of thyroid disorders across India. With AI integration on the horizon at AIIMS Bhubaneswar, healthcare providers will soon be equipped to detect thyroid conditions more efficiently and initiate timely treatment.
Personalized Medicine for Hypothyroidism
As reported by The Print, Dr. Biswas emphasized the increasing role of AI in delivering personalized medicine, particularly for hypothyroidism. This condition currently affects approximately 1 in 10 adults in India. By leveraging AI tools, clinicians can tailor treatments to individual needs, track disease progression, and monitor responses to medications effectively.
Reaching Rural and Underserved Populations
Importantly, the AI-based diagnostic system will be especially beneficial for patients in rural and underserved regions. It aims to bridge the healthcare gap by offering accessible and timely diagnosis, thus reducing the number of undiagnosed cases.
Women More Vulnerable to Hypothyroidism
Dr. Biswas pointed out that hypothyroidism is three times more prevalent in women than in men. Alarmingly, around 33% of cases remain undiagnosed. Without proper treatment, hypothyroidism can severely affect vital organs such as the heart, brain, kidneys, liver, intestines, and reproductive system.
Serious Consequences in Children
He further noted that untreated hypothyroidism in children and infants can lead to stunted growth, obesity, developmental delays, and poor academic performance. Therefore, timely diagnosis and intervention are critical to prevent long-term health complications.
Conclusion
In summary, the integration of AI in thyroid care promises a significant leap forward in India’s healthcare system. With its potential to enhance early detection, guide personalized treatment, and expand access to quality care, AI is set to become a game-changer in managing thyroid disorders.